Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCambridge Cog Share News (COG)

Share Price Information for Cambridge Cog (COG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 42.00
Bid: 41.00
Ask: 43.00
Change: 0.00 (0.00%)
Spread: 2.00 (4.878%)
Open: 42.00
High: 42.00
Low: 42.00
Prev. Close: 42.00
COG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

EARNINGS AND TRADING: Cambridge Cognition launches AQUA solution

Tue, 24th Oct 2023 14:40

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

----------

Xtract Resources PLC - Australia and Africa-focused resources, development and mining company - Says gold production in the second quarter to June 30 was 6,456 ounces, up from 4,522 ounces in the first quarter. Says the average grade was 1.74 grams per tonne, up from 1.51 grams. Adds that it processed 124,523 tonnes of material at its Fair Bride project, up from 107,023 tonnes. Notes that the average gold price for the second quarter was USD1,989 per ounce. Notes that its Manica project produced 395 ounces, of which it received 84 ounces. Chair Colin Bird says: "During the first half of the year the Fair Bride operation progressed in every aspect of production with financial control and reporting systems being modified and developed by the operator to meet international reporting standards. Similarly, mining and processing was managed by the operator moving towards an operation which will satisfy the requirements necessary for the reporting and management of a small gold operation not withstanding its remoteness."

----------

Belluscura PLC - London-headquartered medical device developer - Says early results from its two-month-old direct-to-consumer programme has exceeded its expectations. Adds that its X-PLOR device has been well received by customers, which it says shows a "significant need and opportunity to provide portable oxygen concentrators to customers not previously served by durable medical equipment companies". Notes that the programme was intended to capture an underserved population of lung disease sufferers. Says it expects the programme to expand significantly with the launch of its DISCOV-R portable oxygen concentrator. Bob Fary, senior vice president of sales and marketing says: "I am very excited about the new direct-to consumer sales program. We have identified a potentially significant sales opportunity that not only benefits the company, but under-represented patients as well."

----------

Cambridge Cognition Holdings PLC - Cambridgeshire, England-based company which develops and markets digital solutions to assess brain health - Launches AQUA quality assurance solution for central nervous system clinical trials. Says AQUA is powered by its Winterlight speech and language platform. Notes that it has already gained a customer for AQUA. Says it believes AQUA has potential to generate GBP16 million per year within five years, based on research into the market opportunity. Adds that there may be further opportunities in other healthcare applications. Chief Executive Matthew Stork comments: "AQUA is an entirely new solution for the clinical trials market providing a level of quality assurance that was not possible before, from a cost or time perspective, with traditional reviews by medical experts. We acquired Winterlight Labs intending to commercialise their innovative verbal clinical assessments and, by launching AQUA, we have achieved the first of our product goals. We are also really pleased to have already won a client for AQUA as we expect this will provide us with an excellent case study for future sales."

----------

Phoenix Copper Ltd - Base and precious metals explorer in the US state of Idaho - Says it is assessing assay results from 28 drill holes from Navarre Creek, with the initial seven holes indicating a continuous zone of low-grade mineralisation. Notes that it has added 400 acres of unpatented mining claims to the southwest end of its block, in order to ensure the control of the property during evaluation, as the zone appears to trend to the southwest, off its current property. Chief Executive Ryan McDermott says: "We are currently assessing all of the results, so that we can put them into context with the geologic system as we currently understand it. However, gold values from the first target area, comprised of seven holes along the strike of the Lehman Creek fault, show a clearly defined low-grade gold bearing zone that is continuous across each drill hole...We will release the results of the Navarre Creek exploratory drilling once they have been fully evaluated and placed in the context of the geologic system as a whole, to assist us to determine the drilling priorities for the remaining 32 holes within our planned 60 hole RC drilling program and application for additional drill permitting for the 2024 field season."

----------

Castillo Copper Ltd - base metal explorer primarily focused on copper across Australia and Zambia - Says it has endorsed its geology team's recommendation to classify NWQ Copper Project as a core asset. Says that due to this it will begin a campaign to "deepen its understanding of the 20+ prospects across the tenure" prior to engaging with strategic partners. Says its geology team has conducted field trips to identify future exploration targets. Chair Ged Hall says: "With over 20 prospects across the NWQ Copper Project, which is now earmarked as a core asset, the geology team has considerable work ahead to fully assess the collective exploration potential. This is critical information to have mapped out as the Board channels its efforts into aligning with a strategic development partner."

----------

By Harvey Dorset, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
23 Oct 2014 09:08

Cambridge Cognition Launches New Product CTIS-Profile 2+

Read more
29 Sep 2014 11:54

DIRECTOR DEALINGS: Cambridge Cognition CEO And CFO Buy Shares

Read more
24 Sep 2014 08:58

DIRECTOR DEALINGS: Cambridge Cognition CEO And CFO Buy Shares

Read more
11 Sep 2014 10:21

Cambridge Cognition Narrows Pretax Loss In First-Half

Read more
13 Aug 2014 09:28

Cambridge Cognition Expands Partnership With Altreos Research

Read more
2 Jul 2014 08:50

Cambridge Cognition To Meet Full-Year Expectations As Half Year Ahead

Read more
26 Jun 2014 09:50

Cambridge Cognition Confident For Full-Year On Contract Wins

Read more
5 Jun 2014 09:34

Cambridge Cognition Holdings Signs Contracts For Cognitive Safety Trial

LONDON (Alliance News) - Cambridge Cognition Holdings PLC said Thursday that it has signed a contract for a global multi-year study in which its Cantab Solutions technology will be used to assess the cognitive safety of a new medicine under development for cardiovascular disease. The contra

Read more
3 Jun 2014 08:12

Cambridge Cognition Launches First iPad Product For Clinical Trials

LONDON (Alliance News) - Cambridge Cognition Holdings PLC said Tuesday that it had launched the first of its two iPad-based products on its Cantab Connect digital platform for use in clinical trials. Its product, called The Clinical Trials Information System Adverse Effects, allows for the

Read more
28 May 2014 10:08

Cambridge Cognition rolls out new health app in Lincolnshire

Computerised neuropsychological test specialists Cambridge Cognition announced its Cantab Mobile app has been released by North East Lincolnshire Clinical Commissioning Group into the medical sector. The group's app will be introduced to five GP surgeries, five pharmacies and Grimbsy hospital to he

Read more
28 May 2014 10:00

Cambridge Cognition Mobile App Rolled Out In North East Lincolnshire

LONDON (Alliance News) - Cambridge Cognition Holdings PLC said Wednesday that the North East Lincolnshire Clinical Commissioning Group has introduced its Cantab mobile app in five GP surgeries, five pharmacies and Grimsby hospital to help diagnose dementia earlier. The firm, which specialis

Read more
8 May 2014 11:58

Cambridge Cognition Reiterates Confidence On Return To Growth

LONDON (Alliance News) - Cambridge Cognition Holdings PLC Thursday reiterated confidence that it would be able to return to growth in 2014, in a statement ahead of its annual general meeting. The biotechnology company said that it had seen a positive start to trading in the first quarter of

Read more
2 Apr 2014 10:29

Cambridge Cognition Appoints Non-Executive Chairman

LONDON (Alliance News) - Cambridge Cognition Holdings PLC said Wednesday it has appointed Michael Lewis as non-executive Chairman. The company, which specialises in computerised neuropsychological tests including those enabling the early detection of dementia, said Lewis will take over from

Read more
13 Mar 2014 12:08

Cambridge Cognition Confident For Return To Growth In 2014

LONDON (Alliance News) - Cambridge Cognition Holdings PLC expressed confidence Thursday that it would return to growth in 2014, after it posted a widened pretax loss in 2013 due to lower revenue. Cambridge Cognition provides computerised neuropsychological tests, particularly to enable earl

Read more
3 Mar 2014 11:00

Cambridge Cognition Launches Latest Research Software

LONDON (Alliance News) - Cambridge Cognition Holdings PLC said Monday it has launched the Cantab Research Suite, the latest offering in its cognitive testing platform for academic research. Cambridge, which specialises in computerised neuropsychological tests, such as those enabling the ear

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.